ClinicalTrials.Veeva

Menu

Characterization and Epigenetics of Post-Partum Preeclampsia

Duke University logo

Duke University

Status

Terminated

Conditions

Post Partum Pre-eclampsia

Treatments

Other: no intervention

Study type

Observational

Funder types

Other

Identifiers

NCT02935556
PRO00104636

Details and patient eligibility

About

This study will recruit women with post partum pre-eclampsia and match them to controls without postpartum pre-eclampsia to identify an epigenetic signature that is specific to women with post partum pre-eclampsia to help characterize the underlying pathophysiology of post partum pre-eclampsia.

Full description

Preeclampsia (PEC) is a heterogeneous disease that complicates 5-8% of pregnancies. Approximately 10% of PEC patients will present with post-partum PEC without having developed the syndrome during the pregnancy (PP-PEC). Management of post-partum preeclampsia (PP-PEC) is challenging because many women do not seek care until neurologic symptoms result from severe-range elevated blood pressure. The pathogenesis and clinical characteristics of PP-PEC are understudied and poorly understood. Identifying clinical risk factors and biomarkers of PP-PEC would help to identify women at risk.

Enrollment

12 patients

Sex

Female

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Post partum pre-eclampsia

Matching based on:

  • maternal age (years +/-3)
  • BMI (+/-5 points)
  • Ethnicity
  • Mode of delivery
  • Gestational age at delivery (+/7 days)
  • Smoking status

Exclusion criteria

  • Intrapartum pre-eclampsia

Trial design

12 participants in 2 patient groups

post partum pre-eclampsia
Description:
women with normal deliveries followed by post partum pre-eclampsia within 1 month of delivery.
Treatment:
Other: no intervention
controls
Description:
women with normal deliveries and normal post part courses who match the post partum pre-eclampsia women in age, BMI, smoking status, gestational age and race/ethnicity.
Treatment:
Other: no intervention

Trial contacts and locations

2

Loading...

Central trial contact

Marie-Louise Meng, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems